【Company News】Xianggen Biotech and Endotarget Biotech of the United States have reached a cooperation agreement, and the two sides will work together to accelerate the global development of related PROTAC drugs

On May 20, 2022, Shenzhen Xianggen Biological Co., Ltd. […]